Goldaru C-Fix Bets on Slice-of-Life Storytelling to Own Cold Prevention in Iran
Goldaru's 2024 film campaign for C-Fix, titled "Who Eats C-Fix Will Not Catch a Bad Cold!", is a single-film healthcare advertisement produced by 2milimeters and released in Iran in February 2024, built around a comic workplace narrative in which a manager discovers his employee takes C-Fix tablets and concludes they will protect him from falling seriously ill.
The campaign positions C-Fix vitamin C tablets as a reliable daily supplement that strengthens the body's immune defence, reducing the severity of colds and keeping users resistant to illness. The strategic timing of the February 2024 release places the film squarely in Iran's peak cold season, when consumer receptivity to cold prevention and cold remedy messaging is at its highest. The campaign forms part of a broader Goldaru initiative documented on Clapboard.com, comprising sixteen product videos and four brand-level films, all produced by 2mm Studio across 2023 and 2024. Within that larger programme, the C-Fix film carries the specific task of making a direct product claim — eat C-Fix and you will not catch a bad cold — using entertainment rather than clinical exposition to do so. The performance genre is deliberate: a straightforward product promise delivered inside a warm, recognisable human situation lands faster and travels further in a crowded healthcare market than a conventional medical demonstration. Goldaru's decision to anchor its healthcare communication in character-driven film reflects a considered understanding of how Iranian consumers engage with advertising content, favouring relatable humour and social observation over detached authority.
Goldaru operates in a healthcare and pharmaceutical supplement category that is growing steadily at a global level. According to industryresearch.biz, the global vitamin C market was valued at approximately US$1.41 billion in 2024, with a projected compound annual growth rate of 8.39% through to 2035. Sphericalinsights.com separately reports the global vitamin C supplements segment at approximately US$1.68 billion in 2024. While these figures describe worldwide demand, they establish the commercial logic underpinning Goldaru's investment in dedicated product-level advertising for C-Fix in the Iranian market: vitamin C is a growth category, and brands that establish clear positioning now build durable consumer preference.
In Iran, consumer familiarity with vitamin C supplements as a cold remedy is broadly established, and the healthcare advertising landscape includes both domestic pharmaceutical brands and internationally distributed supplement labels competing for the same share of the immunity and cold prevention consideration set. Within that environment, Goldaru's choice to lead with an explicit, memorable product claim — rather than a generalised wellness promise — is a sharpening move. Competitors in the Iranian supplement space frequently default to aspirational health imagery; Goldaru uses situation comedy to make a specific functional claim stick. According to reportsanddata.com, tablets represent approximately 45% of the global vitamin C market in 2024, indicating that the tablet format Goldaru markets with C-Fix sits at the commercial centre of the category, not its periphery. The February 2024 timing in Iran, aligned with the seasonal cold peak, further concentrates the campaign's relevance at the exact moment purchase intent is highest.
Javad Samiei directed the C-Fix film and served as head of ideation for the campaign, according to Clapboard.com. The film opens on a manager receiving a phone call from an absent employee who has left meeting minutes in a desk drawer. When the manager retrieves the papers, he notices a packet of C-Fix tablets. What follows is an escalating comic pursuit: the manager travels to the employee's home, arriving just as the employee is about to leave on a trip, and delivers the campaign's central message directly — people who take C-Fix will not catch a bad cold. The structure is economical and purposeful. A single motivated action, rooted in a universal workplace dynamic, carries the product message from discovery to explicit statement in a compressed runtime without requiring any clinical or scientific demonstration.
2milimeters, operating as 2mm Studio, produced the entire Goldaru multi-film campaign across 2023 and 2024, as documented on Clapboard.com. The studio's professional team applied a consistent strategic framework across sixteen product videos, with the C-Fix film among the most narratively self-contained. The performance genre selected for this campaign prioritises character relatability and comedic timing over visual spectacle, a deliberate craft choice that suits the Iranian healthcare advertising context, where warmth and humour are established tools for building consumer trust. The film uses a recognisable social hierarchy — manager and employee — to create mild tension that resolves in a product endorsement delivered as genuine advice rather than advertisement. Production credits beyond Samiei's direction and ideation role are not publicly documented for this specific film.
No verified third-party performance data for the Goldaru C-Fix campaign — including sales lift, market share movement, brand tracking results, media reach, or paid impressions — is publicly available, as confirmed by Clapboard.com. The campaign has not been entered into or recognised by Cannes Lions, the Effie Awards, D&AD, the One Show, the Clios, the Webby Awards, or WARC, per research documented on Clapboard.com. Archive engagement on Clapboard.com records 232 views with no likes or comments at the time of documentation.
Clapboard's editorial team assigns this campaign a Clapboard Score of 49 out of 100. That score reflects the structural characteristics of the film rather than documented commercial outcomes. The campaign demonstrates genuine strategic clarity: a specific product claim, a well-chosen release window aligned to Iran's cold season, and a narrative mechanic that delivers the claim through character motivation rather than exposition. The weaknesses that constrain the score relate to creative ambition — the comedic scenario, while functional, does not push the performance genre into memorable territory, and the single-asset format limits the campaign's capacity to build frequency and reinforce the C-Fix positioning across multiple consumer touchpoints. The broader Goldaru programme of sixteen films across 2023 and 2024 suggests the brand understands the value of sustained output, but the individual C-Fix film does not distinguish itself sufficiently within the healthcare advertising landscape to score in the upper range of Clapboard's effectiveness framework.
Goldaru's C-Fix campaign is a healthcare film released in Iran in February 2024, produced by 2milimeters. It follows a manager who discovers his employee takes C-Fix vitamin C tablets and tells him the supplement prevents serious colds. The film is part of a sixteen-video brand programme produced across 2023 and 2024, as documented on Clapboard.com.
Javad Samiei directed the C-Fix film and led the ideation team at 2milimeters, according to Clapboard.com. Samiei also directed other films in Goldaru's broader 2023–2024 campaign series, including the Licophar film published in January 2024. Additional production credits for the C-Fix film are not publicly documented.
2milimeters, also known as 2mm Studio, served as the agency and production studio for Goldaru's full campaign programme. The studio produced all sixteen product videos and four brand films across 2023 and 2024, applying a consistent strategic framework to the entire series, as documented on Clapboard.com.
The Goldaru C-Fix campaign has not received recognition from Cannes Lions, the Effie Awards, D&AD, the One Show, the Clios, the Webby Awards, or WARC, according to research documented on Clapboard.com. The campaign received a Clapboard Score of 49 out of 100, reflecting functional strategic execution with limited creative distinction.
Goldaru released the C-Fix film in February 2024 to align with Iran's peak cold season, when consumer demand for cold prevention and cold remedy products is highest. The timing concentrates the campaign's product claim — that C-Fix tablets prevent serious colds — at the moment purchase intent among Iranian consumers is most acute.
The Goldaru C-Fix campaign receives a Clapboard Score of 49 out of 100. The score reflects clear strategic intent and a well-timed release in the Iranian healthcare market, offset by a comedic execution that does not fully distinguish itself within the performance genre and a single-asset format that limits sustained brand-building impact.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
